Golden Throat successfully coughs up $108m IPO

The Chinese throat lozenges maker overcame turbulent markets to complete its Hong Kong IPO after trading in a quarter of A-share-listed companies was suspended.

Chinese lozenges maker Golden Throat overcame testing market conditions on Tuesday to successfully price its initial public offering in Hong Kong, albeit near the bottom of its indicative range as Chinese share worries continued to swirl.

Beijing suspended new share sales over the weekend in a bid to stabilise the country’s stock markets, after these fell almost 30% in three weeks. Some 760 companies more than a quarter of all A-share listed-companies on the Shanghai and Shenzhen exchanges have also so far suspended share trading, according to media reports.

Golden Throat, a very well known cough sweet maker in China,...
¬ Haymarket Media Limited. All rights reserved.

FinanceAsia has updated its subscription model.

Registered readers now have the opportunity to read 5 articles from our award-winning website for free.

To obtain unlimited access to our award-winning exclusive news and analysis, we offer subscription packages, including single user, team (2-10 users), or office-wide licences.

To help you and your colleagues access our proprietary content, please contact us at subscriptions@financeasia.com, or +(852) 2122 5222

Article limit is reached.

Hello! You have used up all of your free articles on FinanceAsia.

To obtain unlimited access to our award-winning exclusive news and analysis, we offer subscription packages, including single user, team (2-10 users), or office-wide licences. To help you and your colleagues access our proprietary content, please contact us at subscriptions@financeasia.com, or +(852) 2122 5222